Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
Titel:
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials
Auteur:
Berger, M.D. Stintzing, S. Heinemann, V. Yang, D. Cao, S. Sunakawa, Y. Ning, Y. Matsusaka, S. Okazaki, S. Miyamoto, Y. Suenaga, M. Schirripa, M. Soni, S. Zhang, W. Falcone, A. Loupakis, F. Lenz, H.-J.